Narrowband UVB Phototherapy

Treatment for Vitiligo

Typical Dosage: 2-3 sessions per week, gradually increasing dose from 200-300 mJ/cm²

Effectiveness
70%
Safety Score
70%
Clinical Trials
12
Participants
20K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
2-3 sessions per week, gradually increasing dose from 200-300 mJ/cm²
Time to Effect
2-3 months
Treatment Duration
6-24 months
Evidence Quality
HIGH
Number Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$300
Side Effect Mgmt:$100
Total Annual:$8,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$40,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$13,333.33
Cost per Remission
$32,000
Narrowband UVB Phototherapy Outcomes

for Vitiligo

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+60%
Remission Rate
+25%
Common Side Effects
Erythema
+60%
Pruritus
+25%
Dryness
+20%
Increased skin cancer risk (long-term)
+1%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Narrowband UVB Phototherapy in Vitiligo

Vitiligo, New Treatment and Serum s100B

NCT06768840RECRUITINGPHASE2, PHASE3
View Study
50 participants
INTERVENTIONAL
Qina, Egypt
Started: Oct 2, 2024
Completed Clinical Trials
7 completed trials for Narrowband UVB Phototherapy in Vitiligo

Narrowband UVB Treatment in Patients With Vitiligo

NCT00398723COMPLETEDNA
View Study
20 participants
INTERVENTIONAL
New York, United States
Started: Nov 1, 2006

NB-UVB and PUVA Vitiligo Study

NCT01732965COMPLETEDPHASE4
View Study
10 participants
INTERVENTIONAL
Detroit, United States
Started: Mar 1, 2013

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

NCT04547998COMPLETEDNA
View Study
25 participants
INTERVENTIONAL
Irvine, United States +11 more
Started: Sep 10, 2020

HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home

NCT01478945COMPLETEDNA
View Study
29 participants
INTERVENTIONAL
Nottingham, United Kingdom +1 more
Started: Feb 1, 2012

Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo

NCT03123016COMPLETEDPHASE2
View Study
23 participants
INTERVENTIONAL
New York, United States
Started: Apr 14, 2017

Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy

NCT03270241COMPLETEDNA
View Study
10 participants
INTERVENTIONAL
Baltimore, United States
Started: Oct 1, 2017

Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency

NCT05364567COMPLETEDNA
View Study
29 participants
INTERVENTIONAL
Seoul, South Korea
Started: May 1, 2018